Zobrazeno 1 - 2
of 2
pro vyhledávání: '"MESH: Natural Killer T-Cells/immunology"'
Autor:
Trottein, François, Paget, Christophe
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Frontiers, 2018, 9, ⟨10.3389/fimmu.2018.01750⟩
Frontiers in Immunology, Frontiers, 2018, 9, pp.1750. ⟨10.3389/fimmu.2018.01750⟩
Frontiers in Immunology, 2018, 9, pp.1750. ⟨10.3389/fimmu.2018.01750⟩
Frontiers in Immunology, Frontiers, 2018, 9, ⟨10.3389/fimmu.2018.01750⟩
Frontiers in Immunology, Frontiers, 2018, 9, pp.1750. ⟨10.3389/fimmu.2018.01750⟩
Frontiers in Immunology, 2018, 9, pp.1750. ⟨10.3389/fimmu.2018.01750⟩
International audience; The immune system has been traditionally divided into two arms called innate and adaptive immunity. Typically, innate immunity refers to rapid defense mechanisms that set in motion within minutes to hours following an insult.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::22dce94e29209241a8a43a5206dc942b
http://hdl.handle.net/20.500.12210/55830
http://hdl.handle.net/20.500.12210/55830
Autor:
Emilie Bialecki, François Trottein, Luis J. Cruz, Josette Fontaine, Reem Ghinnagow, Elodie Macho-Fernandez, Benoît Frisch, Christelle Faveeuw
Publikováno v:
Journal of Immunology
Journal of Immunology, Publisher : Baltimore : Williams & Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists, 2014, 193 (2), pp.961-969. ⟨10.4049/jimmunol.1303029⟩
Journal of Immunology, 193(2), 961-969
Journal of Immunology, 2014, 193 (2), pp.961-969. ⟨10.4049/jimmunol.1303029⟩
Journal of Immunology, Publisher : Baltimore : Williams & Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists, 2014, 193 (2), pp.961-969. ⟨10.4049/jimmunol.1303029⟩
Journal of Immunology, 193(2), 961-969
Journal of Immunology, 2014, 193 (2), pp.961-969. ⟨10.4049/jimmunol.1303029⟩
Immunotherapy aiming at enhancing innate and acquired host immunity is a promising approach for cancer treatment. The invariant NKT (iNKT) cell ligand α-galactosylceramide (α-GalCer) holds great promise in cancer therapy, although several concerns
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89d564a81d30efc92538f3b7fbb6a0b5
https://www.hal.inserm.fr/inserm-02436034
https://www.hal.inserm.fr/inserm-02436034